ASG Webinar Series

Session 4: IBD Clinical Trials - Importance of Ongoing Pharmacological Trials 

Tuesday, December 3, 2024 at 5:30 pm

Presenter:

Dr. Remo Panaccione

is a Professor of Medicine at the University of Calgary and the Director of the Inflammatory Bowel Disease (IBD) Clinic and Gastrointestinal Research. He is an internationally recognized expert in inflammatory bowel disease with a special focus on clinical trials for new IBD therapies. Dr. Panaccione's research includes identifying new targets for IBD treatment, and his work has positioned the University of Calgary's IBD Clinical Trials Unit among the top five globally.

Moderator:

Dr. Karen Kroeker

Director of the ASG, Co-Chair of Education

Learning Objectives

  • Recognize which patients to refer to pharmacologic clinical trials
  • Describe benefits of participation in industry sponsored research (researchers and patients)

Registration now open


Industry Symposium:

From Clinical Trials to Clinical Practice

Join us after the webinar on December 3 from 6:40 - 7:00pm MST for a special industry symposium.
Funding for this symposium has been generously provided by Janssen.

Presenter:

Dr. Remo Panaccione

is a Professor of Medicine at the University of Calgary and the Director of the Inflammatory Bowel Disease (IBD) Clinic and Gastrointestinal Research. He is an internationally recognized expert in inflammatory bowel disease with a special focus on clinical trials for new IBD therapies. Dr. Panaccione's research includes identifying new targets for IBD treatment, and his work has positioned the University of Calgary's IBD Clinical Trials Unit among the top five globally.

Moderator:

Dr. Karen Kroeker

Director of the ASG, Co-Chair of Education

Learning Objectives:

 After this program, the participants will be able to:

  • Review the key concepts in interpreting the results of clinical trials
  • Review the importance of clinical trials, & how they have shaped the modern practice of IBD

Registration is for both events.  Registration now open


Session 1:

Monday, June 17, 2024 at 5:00pm

In this webinar, participants will have the opportunity to learn and ask questions about Celiac disease.


Presenter:

Dr. Justine Turner and Dr. Sander van Zanten

Dr. Justine Turner is a pediatric gastroenterologist and Professor at the University of Alberta.  She is medical lead for the Multidisciplinary Pediatric Celiac Disease Clinic at Stollery Children’s Hospital Edmonton. She is a long member of the Professional Advisory Council for the Canadian Celiac Association and Medical Advisor for the Edmonton Chapter of the Canadian Celiac Association.

and

Dr. Veldhuyzen van Zanten has been a member of the University of Alberta GI Division since 2006. He.is an Academic Gastroenterologist who went to medical school and did his Internal Medicine training in Holland. He did his GI training and a Master’s in Clinical Epidemiology at McMaster’s University in Hamilton, Canada from 1986 to 1990. In 1992, he received a PhD in Medicine on the topic of "Clinical Aspects of Helicobacter pylori infection" from the University of Amsterdam.

Moderator:

Dr. Karen Kroeker,

Director of the ASG, Co-Chair of Education

Learning Objectives: 

  • Describe key treatment decision points in the new pathway for management of Celiac disease;
  • Explain the benefits that could be achieved through harmonization of lab testing across Alberta, and the impact that treatment algorithms may have on testing;
  • Review opportunities for quality improvement that may be achieved via use of the pathway
  • Discuss a maximum wait time of < 8weeks for biopsy confirmation of the diagnosis.

Recording available here for members. 



Session 2: Sarcopenia, Malnutrition in IBD and Cirrhosis of the Liver

Tuesday, September 10, 2024 at 5:30 pm
Join us for an interactive session where members can inquire about sarcopenia in liver disease and inflammatory bowel disease (IBD), get insights on current evidence-based recommendations, best practices for patient management, and engage in live Q&A throughout the presentation.

Presenter:

Dr. Maitreyi Raman, Physician Nutrition Specialist, Medical Educator and Clinical Associate Professor, University of Calgary

and

Dr. Puneeta Tandon, Hepatologist and founder of the Cirrhosis Care Clinic at the University of Alberta Hospital


Moderator:

Dr. Jesse Siffledeen 

President of the ASG

Learning Objectives:

  • Explain the pathophysiology of sarcopenia in liver disease, including the impact of cirrhosis on muscle wasting and its association with malnutrition.
  • Describe the relationship between malnutrition and inflammatory bowel disease (IBD).
  • Evaluate evidence-based strategies for the management of sarcopenia, malnutrition in IBD, and cirrhosis of the liver, focusing on interventions aimed at optimizing nutritional status and preserving muscle mass.

Recording available here for members


Session 3: EtOH Cessation - Counselling, Pharmacological, Success rate

Tuesday, October 15, 2024 at 5:30 pm


Presenter:

Dr. Monty Ghosh

Monty Ghosh is an Internist and Addiction Specialist who works at the University of Alberta Hospital in Edmonton as an Internist as well as the Foothills and Rockyview Hospitals doing Addiction Medicine in Calgary.  He has worked with multiple community-based not-for-profit organizations to provide support for marginalized populations including The Alex and The Calgary Drop-In Centre. He also helps foster and create unique programs to support those living with substance use, experiencing homelessness, and with other vulnerabilities.  He is the Medical Co-Lead for the AHS Rapid Access Addiction Medicine (RAAM) Program.

He has addiction certification through the International Society of Addiction Medicine, and a Masters Public Health from Harvard University.  He is an assistant professor at both The University of Alberta and the University of Calgary, and is heavily involved with provincial policy building in Alberta, as well as with research and is the primary recipient of grants from Health Canada, Alberta Innovates, Alberta Health, and the Canadian Institute of Health Research. 

He is also the co-chair of the Canadian Network for the Health and Housing of People Experiencing Homelessness (CNH3).


Moderator:

Dr. Stephen Congly,

ASG, Vice-President


Learning Objectives:


  • Review the role of counseling in alcohol cessation
  • Explore pharmacological treatments for alcohol cessation
  • Assess success rates of various alcohol cessation strategies

Recording available here for members.

This webinar has received an educational grant or in-kind support from:


Celltrion, Janssen, Pfizer, AbbVie, Amgen, Gilead, Organon, Fresinius Kabi, Bausch, Pendopharm, Pentax, McKesson, Sanofi, BioScript, Biojamp, Boston Scientific, SRX Health, Takeda, Lilly, Lupin, McKesson, Sandoz, Novo Nordisk, Sanofi, Cencora Innomar Strategies